Cargando…
Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine
Protein tyrosine phosphatase 1B (PTP1B) is an enzyme crucially implicated in aberrations of various signaling pathways that underlie the development of different human pathologies, such as obesity, diabetes, cancer, and neurodegenerative disorders. Its inhibition can prevent these pathogenetic event...
Autores principales: | Maccari, Rosanna, Ottanà, Rosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253921/ https://www.ncbi.nlm.nih.gov/pubmed/37298571 http://dx.doi.org/10.3390/ijms24119621 |
Ejemplares similares
-
Sodium-Glucose
Cotransporter Inhibitors as Antidiabetic
Drugs: Current Development and Future Perspectives
por: Maccari, Rosanna, et al.
Publicado: (2022) -
The PTP1B Inhibitor Trodusquemine (MSI-1436) Improves Glucose Uptake in Equine Metabolic Syndrome Affected Liver through Anti-Inflammatory and Antifibrotic Activity
por: Bourebaba, Lynda, et al.
Publicado: (2023) -
Deconstructing allostery by computational assessment of the binding determinants of allosteric PTP1B modulators
por: Hardie, Adele, et al.
Publicado: (2023) -
From Marine Metabolites to the Drugs of the Future: Squalamine, Trodusquemine, Their Steroid and Triterpene Analogues †
por: Kazakova, Oxana, et al.
Publicado: (2022) -
Studying the trafficking of labeled trodusquemine and its application as nerve marker for light‐sheet and expansion microscopy
por: Capitini, Claudia, et al.
Publicado: (2022)